Study Stopped
Study must be registered under the sponsor instead of the site, so we have created a new posting in the sponsor's account.
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
Smartphone Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: A Randomized, Waitlist-control Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for obsessive compulsive disorder (OCD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in Y-BOCS scores than those in the waitlist condition at treatment endpoint (week 12).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2018
CompletedFirst Posted
Study publicly available on registry
December 6, 2018
CompletedStudy Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedAugust 8, 2022
May 1, 2020
2.9 years
December 5, 2018
August 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in OCD severity (Y-BOCS) at the end of treatment/waitlist period.
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is the gold-standard, semi-structured clinician-administered assessment of OCD severity. It contains 10 items ranging from 0 to 4, which are summed to generate a total score (range = 0-40). Higher scores indicate more severe OCD symptoms. The Y-BOCS will be used to assess change in OCD symptoms from baseline to endpoint.
Endpoint (week 12)
Secondary Outcomes (3)
Difference in depression at the end of treatment/waitlist period
Endpoint (week 12)
Difference in functional impairment at the end of treatment/waitlist period
Endpoint (week 12)
Difference in quality of life at the end of treatment/waitlist period
Endpoint (week 12)
Study Arms (2)
Smartphone-delivered CBT for OCD
EXPERIMENTAL12-week Smartphone delivered CBT for OCD.
12 Week Waitlist Control
OTHER12-week waitlist control. (Note: participants will be crossed over to 12-week Smartphone-delivered CBT for OCD following the 12-week waitlist control).
Interventions
12-week Smartphone-delivered CBT for OCD. In-person cognitive-behavioral therapy (CBT) is an empirically supported treatment for OCD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Eligibility Criteria
You may qualify if:
- at least 18 years of age
- current diagnosis of primary DSM-5 OCD, based on MINI
- currently living in the United States
You may not qualify if:
- Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
- Past participation in ≥ 4 sessions of CBT for OCD
- Current severe substance use disorder
- Lifetime bipolar disorder or psychosis
- Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥ 2 on the suicidal ideation subscale of the C-SSRS
- Current severe comorbid major depression, as indicated by clinical judgment and/or a QIDS-SR total score ≥ 21
- Concurrent psychological treatment
- Does not own a supported mobile Smartphone with a data plan
- Lack of technology literacy that would interfere with ability to engage with smartphone treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Telefónica S.A.collaborator
Study Sites (1)
Anna Schwartzberg
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine Wilhelm, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Psychology
Study Record Dates
First Submitted
December 5, 2018
First Posted
December 6, 2018
Study Start
July 1, 2019
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
August 8, 2022
Record last verified: 2020-05